Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 13th May 2020
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Joint statement on the use of flukicides in dairy cattle
'When prescribing, it is important to be aware of the withdrawal period requirements'

Document contains a summary of the various products available.

A joint statement on the use of flukicides in dairy cattle has been released by the National Office of Animal Health (NOAH) and the Veterinary Medicines Directorate (VMD).

Flukicides are anthelmintic veterinary medicines that are active against parasites from the trematode class. The most common parasite in this class is the liver fluke.

The statement reads: 'Vets, Suitably Qualified Persons (SQPs) and farmers are generally required to follow the instructions on the product labels; however, the prescribing decision rests with the vet, pharmacist or SQP.

'When prescribing, it is important to be aware of withdrawal period requirements specified on the labels and farmers should follow the advice given by the vet or the SQP.'

The statement also contains a summary of the various dairy cattle flukticides products authorised for sale in the UK.

Because some of the products place restrictions on the use of the product depending on the stage of pregnancy, users and prescribers are urged to consider this information carefully when treating animals. 

The full document can be read here.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.